Gyrodyne , LLC shares had a trading volume of 11 on Tuesday. Shares saw a steep decrease in trading volume of 93.82% under the normal average daily volume.
Investors are feeling more bullish on the company if you put credence in the decrease in short interest. The stock experienced a fall in short interest from September 29, 2017 to October 13, 2017 of -5.66%. Short shares fell 179 over that timeframe. The days to cover increased to 8.0 and the percentage of shorted shares is 0.00% as of October 13.
Gyrodyne , LLC (NASDAQ:GYRO) has been the object of insider buying activity recently. Paul L. Lamb, Director disclosed the purchase of 1,500 shares of (GYRO). The shares were purchased at an average price of $20.44. The Director now owns $89,282 of the stock per the Form 4 SEC filing.
These firms have modified their investment in GYRO. As of the end of the quarter Tower Research Capital LLC (trc) had disposed of a total of 500 shares trimming its stake by 83.3%. The value of the investment in GYRO went from $11,000 to $2,000 a change of $9,000 for the reporting period. Gabelli Funds LLC augmented its ownership by buying 1,000 shares an increase of 3.3%. Gabelli Funds LLC claims 31,367 shares with a value of $643,000. The value of the position overall is up by 2.2%.
Css LLC/il reduced its investment by shedding 500 shares a decrease of 1.1% as of 06/30/2017. Css LLC/il owns 43,003 shares worth $881,000. The total value of its holdings decreased 2.2%. As of quarter end Ubs Group Ag had bought 1,697 shares growing its position 543.9%. The value of the company’s investment in Gyrodyne , LLC increased from $6,000 to $41,000 a change of 583.3% quarter over quarter.
The company is so far trading unchanged by 0.00% percent from yesterday’s close. Shares are trading at $21.18 which is marginally higher than the 50 day moving average which is $21.07 and which is marginally over the 200 day moving average of $20.70. The 50 day moving average went up $0.11 or +0.503% and the 200 day average moved up $0.48.
Gyrodyne, LLC, launched on October 3, 2013, is involved in the business of investing and acquiring, owning and managing of a geographically diverse portfolio of real estate properties. The Business’s property portfolio includes medical office, industrial and development of industrial and residential properties located in the Northeast region of the United States. It operates primarily in the management of multi-tenanted industrial and medical office buildings segment. It owns, operates, and manages over 260,000 square feet of rental space, which consists of approximately 20 buildings located on over two properties in Long Island, New York and over two others, including one in northern Westchester County, New York and the other in Fairfax County, Virginia. The Long Island facilities include the Flowerfield Industrial Park in Saint James and the Port Jefferson Professional Park in Port Jefferson Station, New York, while the Westchester property consists of the Cortlandt Medical Center in Cortlandt Manor, New York..